To establish average money market account rates, Curinos focused on accounts intended for personal use. Money market accounts that fall into specific categories are excluded, including promotional ...

Methodology To establish average savings account rates, Curinos focused on savings accounts intended for personal use. Savings accounts that fall into specific categories are excluded, including ...

Shares of energy companies rose as traders rotated into rate-sensitive sectors after the head of the Chicago Federal Reserve called for more rate cuts. Oil futures fell after Iran's prime minister ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of industrial and transportation companies fell as traders recalibrated rate expectations ... and taken private by investment firm for $3.6 billion in cash. In a bad sign for global ...

The best 3-year CD rate is 4.10% APY from Customers Bank and Heartland Credit Union. To find you the highest 3-year CD rates nationwide, we review CD rates from hundreds of banks and credit unions ...

For more opinions on the new MacBook Pro, check out our MacBook Pro review roundup ... 3 offers less interference, lower power consumption, improved encryption, a better experience for those who ...

1507 ET – Gold futures fall for the day, but finished October up 3.9%, its eighth consecutive monthly advance. Gold has gained 34% in those eight months, but the push higher may be running out ...

Producers of metals and other raw materials rose after the European Central Bank cut its interest rates. Gold futures, which are particularly sensitive to rate moves, rose to new all-time highs.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0828 GMT – European pharmaceutical and automotive ...

You’ll earn 4.00% APY on $100,000 and up and 3. ... rates from most of our other picks. Instead, the account performed well in our analysis because of its lack of fees and ease of use.

This week, the European Commission (“EC”) granted approval to Merck’s MRK Keytruda in combination with Pfizer’s PFE Padcev for expanded use in bladder ... 1 and QWINT-3 phase III studies ...